These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24902546)

  • 21. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. End TB Strategy: Time to Move on From the Skin Test to the Interferon-
    Kruse M; Cruikshank W
    Am J Public Health; 2019 Aug; 109(8):1102-1104. PubMed ID: 31268768
    [No Abstract]   [Full Text] [Related]  

  • 23. Immigration screening for latent tuberculosis infection.
    Denholm JT
    Med J Aust; 2013 Jun; 198(10):524. PubMed ID: 23725254
    [No Abstract]   [Full Text] [Related]  

  • 24. Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons.
    Al-Darraji HA; Kamarulzaman A; Altice FL
    BMC Public Health; 2014 Jan; 14():22. PubMed ID: 24405607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited usefulness of the interferon-gamma release assay in patients with HIV infections and negative tuberculin skin test results in a country with an intermediate tuberculosis burden.
    Kim MJ; Nam EY; Park KU; Choe PG; Park WB; Song KH; Kim ES; Kim HB; Oh MD; Kim NJ
    Infect Dis (Lond); 2017 May; 49(5):420-422. PubMed ID: 27822960
    [No Abstract]   [Full Text] [Related]  

  • 27. Active and latent tuberculosis in Brazilian correctional facilities: a cross-sectional study.
    Carbone Ada S; Paião DS; Sgarbi RV; Lemos EF; Cazanti RF; Ota MM; Junior AL; Bampi JV; Elias VP; Simionatto S; Motta-Castro AR; Pompílio MA; de Oliveira SM; Ko AI; Andrews JR; Croda J
    BMC Infect Dis; 2015 Jan; 15():24. PubMed ID: 25608746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Screening for tuberculosis].
    Van Vooren JP; Schepers K
    Rev Med Brux; 2013 Sep; 34(4):301-5. PubMed ID: 24195244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis infection screening in children with close contact: a hospital-based study.
    Sun L; Qi X; Guo Y; Qi H; Li J; Wu X; Yin Q; Guo Y; Xu B; Wang Y; Jin Q; Gao L; Shen A
    BMC Infect Dis; 2021 Aug; 21(1):815. PubMed ID: 34388985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QuantiFERON-TB Gold In-tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia.
    Niguse S; Desta K; Gebremichael G; Gebrezgeaxier A; Getahun M; Kassa D
    BMC Res Notes; 2018 May; 11(1):293. PubMed ID: 29751780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting.
    Mandalakas AM; Kirchner HL; Walzl G; Gie RP; Schaaf HS; Cotton MF; Grewal HM; Hesseling AC
    Am J Respir Crit Care Med; 2015 Apr; 191(7):820-30. PubMed ID: 25622087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zambian prisons "threaten public health" because of high rates of TB and HIV.
    Moszynski P
    BMJ; 2010 Apr; 340():c2225. PubMed ID: 20423968
    [No Abstract]   [Full Text] [Related]  

  • 33. Revision and Implementation of "Clinical Guideline for Tuberculosis and HIV in Prisons", Great Tehran Prison, Iran.
    Farhoudi B; SeyedAlinaghi S; Tabarsi P; Mohraz M; Golrokhy R; Farnia M; Shahbazi M; Alasvand R; Ebrahimi B; Esfehani J; Tashakoriyan M
    Infect Disord Drug Targets; 2018; 18(1):72-80. PubMed ID: 28521672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis incidence and treatment completion among Ugandan prison inmates.
    Schwitters A; Kaggwa M; Omiel P; Nagadya G; Kisa N; Dalal S
    Int J Tuberc Lung Dis; 2014 Jul; 18(7):781-6. PubMed ID: 24902552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing for latent tuberculosis infection using interferon gamma release assays in commercial sex workers at an outreach clinic in Birmingham.
    Daly R; Khatib N; Larkins A; Dedicoat M
    Int J STD AIDS; 2016 Jul; 27(8):676-9. PubMed ID: 26589629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for tuberculosis and testing for human immunodeficiency virus in Zambian prisons.
    Maggard KR; Hatwiinda S; Harris JB; Phiri W; Krüüner A; Kaunda K; Topp SM; Kapata N; Ayles H; Chileshe C; Henostroza G; Reid SE
    Bull World Health Organ; 2015 Feb; 93(2):93-101. PubMed ID: 25883402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk of tuberculosis in healthcare workers: risk assessment and medical surveillance].
    Magrini A; Coppeta L; Somma G; Neri A; Gentili S; Fiocco G; Pietroiusti A
    Ig Sanita Pubbl; 2016; 72(2):137-43. PubMed ID: 27336958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term performance of the IGRA to predict and prevent active tuberculosis development in HIV-infected patients.
    Lee S; Lee JE; Kang JS; Lee SO; Lee SH
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):422-427. PubMed ID: 31064620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing HIV Case Detection in Prison During Opt-In vs. Opt-Out Testing Policies.
    Rosen DL; Wohl DA; Golin CE; Rigdon J; May J; White BL; Leone PA; Hudgens MG; Bowling JM
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):e85-8. PubMed ID: 26536318
    [No Abstract]   [Full Text] [Related]  

  • 40. Latent Tuberculosis screening using interferon-gamma release assays in an Australian HIV-infected cohort: is routine testing worthwhile?
    Doyle JS; Bissessor M; Denholm JT; Ryan N; Fairley CK; Leslie DE
    J Acquir Immune Defic Syndr; 2014 May; 66(1):48-54. PubMed ID: 24457631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.